CHIKAODI BANOR: Open Payments
NPI 1649768953 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 28 payments from 6 companies in 2025. Trend: 2023 $668 · 2024 $242 · 2025 $1,232
Food & beverage: $1,232
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $334 |
| ABBVIE INC. | 6 | $249 |
| Vanda Pharmaceuticals Inc. | 2 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $199 |
| Janssen Pharmaceuticals, Inc | 4 | $175 |
| Lundbeck LLC | 3 | $76 |
Products named: REXULTI, VRAYLAR, FANAPT, CAPLYTA, SPRAVATO.
Industry payments across AZ — which companies pay providers there.
